• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

米非司酮与口服米索前列醇联合用于早期引产:两种米索前列醇剂量方案的比较及其对血压的影响

Early abortion induction by a combination of mifepristone and oral misoprostol: a comparison between two dose regimens of misoprostol and their effect on blood pressure.

作者信息

el-Refaey H, Templeton A

机构信息

Department of Obstetrics and Gynaecology, University of Aberdeen.

出版信息

Br J Obstet Gynaecol. 1994 Sep;101(9):792-6. doi: 10.1111/j.1471-0528.1994.tb11948.x.

DOI:10.1111/j.1471-0528.1994.tb11948.x
PMID:7947529
Abstract

OBJECTIVES

  1. To investigate the efficacy of 800 micrograms misoprostol (a PGE1 analogue) when administered to women pretreated with mifepristone for early pregnancy termination. 2. To establish means of minimising gastrointestinal side effects by comparing two different misoprostol regimens. The impact of these regimens on blood pressure was investigated in a subgroup of patients.

DESIGN

A randomised study of 150 women of 56 days gestation, or less, allocated to receive oral misoprostol either in a single dose of 800 micrograms or as two doses of 400 micrograms administered sequentially 2 h apart; in each case misoprostol was administered 36 to 48 h after receiving mifepristone 200 mg orally.

MAIN OUTCOMES

Complete abortion rates, the frequency and severity (patients' perception) of gastrointestinal side effects, and blood pressure changes in response to prostaglandin administration.

RESULTS

The overall success rate was 93%. Seventy-one (95%) women who received a single dose of misoprostol and sixty-nine (92%) who received the sequential dose aborted completely. There were two ongoing pregnancies in the first group (2.5%) and three (4%) in the second. The overall ongoing pregnancy rate was 3%. The incidence of diarrhoea was significantly lower for women receiving the sequential dose, and no significant differences were found in the incidence of the other gastrointestinal side effects. The only noted significant change in blood pressure was in diastolic pressure 4 h after the administration of the higher dose of prostaglandin, but this was slight.

CONCLUSIONS

The combination of mifepristone and oral misoprostol provides an alternative method to inducing abortion of pregnancies of up to eight weeks gestation. Patients receiving the single dose of 800 micrograms were more troubled by diarrhoea than those on the sequential regimen. The ongoing pregnancy rate was higher than previously reported with vaginal or parenteral administration of prostaglandin.

摘要

目的

  1. 研究米索前列醇(一种前列腺素E1类似物)800微克用于经米非司酮预处理的早期妊娠终止女性时的疗效。2. 通过比较两种不同的米索前列醇给药方案,确定将胃肠道副作用降至最低的方法。在一个亚组患者中研究了这些方案对血压的影响。

设计

一项对150名妊娠56天及以内的女性进行的随机研究,这些女性被分配接受单剂量800微克口服米索前列醇,或分两剂,每剂400微克,间隔2小时依次给药;在每种情况下,米索前列醇均在口服200毫克米非司酮36至48小时后给药。

主要结局

完全流产率、胃肠道副作用的频率和严重程度(患者感受)以及前列腺素给药后的血压变化。

结果

总体成功率为93%。接受单剂量米索前列醇的71名(95%)女性和接受序贯给药的69名(92%)女性完全流产。第一组有2例(2.5%)持续妊娠,第二组有3例(4%)。总体持续妊娠率为3%。接受序贯给药的女性腹泻发生率显著较低,其他胃肠道副作用的发生率未发现显著差异。唯一观察到的显著血压变化是在给予高剂量前列腺素后4小时舒张压有轻微变化。

结论

米非司酮与口服米索前列醇联合使用为妊娠8周及以内的引产提供了一种替代方法。接受800微克单剂量的患者比接受序贯给药方案的患者腹泻困扰更大。持续妊娠率高于先前报道的阴道或胃肠外给予前列腺素的情况。

相似文献

1
Early abortion induction by a combination of mifepristone and oral misoprostol: a comparison between two dose regimens of misoprostol and their effect on blood pressure.米非司酮与口服米索前列醇联合用于早期引产:两种米索前列醇剂量方案的比较及其对血压的影响
Br J Obstet Gynaecol. 1994 Sep;101(9):792-6. doi: 10.1111/j.1471-0528.1994.tb11948.x.
2
The abortifacient effect of misoprostol in the second trimester. A randomized comparison with gemeprost in patients pre-treated with mifepristone (RU486).米索前列醇在孕中期的堕胎效果。与米非司酮(RU486)预处理患者中吉美前列素的随机对照比较。
Hum Reprod. 1993 Oct;8(10):1744-6. doi: 10.1093/oxfordjournals.humrep.a137927.
3
Randomized trial of misoprostol and cervagem in combination with a reduced dose of mifepristone for induction of abortion.米索前列醇与宫颈扩张凝胶联合小剂量米非司酮用于引产的随机试验。
Hum Reprod. 1995 Jun;10(6):1521-7. doi: 10.1093/humrep/10.6.1521.
4
Early induction of abortion by a combination of oral mifepristone and misoprostol administered by the vaginal route.通过口服米非司酮与经阴道给药的米索前列醇联合使用进行早期人工流产。
Contraception. 1994 Feb;49(2):111-4. doi: 10.1016/0010-7824(94)90085-x.
5
Low-dose mifepristone 200 mg and vaginal misoprostol for abortion.低剂量米非司酮200毫克联合阴道用米索前列醇用于流产。
Contraception. 1999 Jan;59(1):1-6. doi: 10.1016/s0010-7824(98)00150-4.
6
Low-dose mifepristone followed by vaginal misoprostol at 48 hours for abortion up to 63 days.低剂量米非司酮随后在48小时后阴道给予米索前列醇用于终止63天内的妊娠。
Contraception. 2000 Jan;61(1):41-6. doi: 10.1016/s0010-7824(99)00119-5.
7
Termination of pregnancy at 9-13 weeks' amenorrhoea with mifepristone and misoprostol.米非司酮与米索前列醇用于停经9 - 13周的终止妊娠。
Lancet. 1998 Aug 15;352(9127):542-3. doi: 10.1016/S0140-6736(05)79250-3.
8
Induction of abortion with mifepristone and misoprostol in early pregnancy.米非司酮与米索前列醇用于早期妊娠流产的引产
Br J Obstet Gynaecol. 1992 Dec;99(12):1004-7. doi: 10.1111/j.1471-0528.1992.tb13707.x.
9
Induction of abortion with mifepristone (RU 486) and oral or vaginal misoprostol.米非司酮(RU 486)与口服或阴道用米索前列醇用于引产。
N Engl J Med. 1995 Apr 13;332(15):983-7. doi: 10.1056/NEJM199504133321502.
10
Early termination of pregnancy with mifepristone (RU 486) and the orally active prostaglandin misoprostol.米非司酮(RU 486)与口服活性前列腺素米索前列醇用于早期终止妊娠。
N Engl J Med. 1993 May 27;328(21):1509-13. doi: 10.1056/NEJM199305273282101.

引用本文的文献

1
Medical methods for first trimester abortion.医学方法终止早期妊娠。
Cochrane Database Syst Rev. 2022 May 24;5(5):CD002855. doi: 10.1002/14651858.CD002855.pub5.
2
Medical termination for pregnancy in early first trimester (≤ 63 days) using combination of mifepristone and misoprostol or misoprostol alone: a systematic review.早期妊娠(≤63 天)人用药物流产:米非司酮配伍米索前列醇或单独应用米索前列醇终止早孕的系统评价。
BMC Womens Health. 2020 Jul 7;20(1):142. doi: 10.1186/s12905-020-01003-8.
3
Medical methods for first trimester abortion.
孕早期人工流产的医学方法。
Cochrane Database Syst Rev. 2011 Nov 9;2011(11):CD002855. doi: 10.1002/14651858.CD002855.pub4.
4
A risk-benefit assessment of oxytocics in obstetric practice.产科实践中缩宫剂的风险效益评估。
Drug Saf. 1999 Apr;20(4):323-45. doi: 10.2165/00002018-199920040-00003.
5
Ergot alkaloids. Current status and review of clinical pharmacology and therapeutic use compared with other oxytocics in obstetrics and gynaecology.麦角生物碱。与妇产科其他宫缩剂相比的临床药理学及治疗用途现状与综述
Drugs. 1998 Oct;56(4):523-35. doi: 10.2165/00003495-199856040-00002.
6
Medical abortion: what does the research tell us?药物流产:研究告诉了我们什么?
CMAJ. 1996 Jan 15;154(2):185-7.